Common, complex diseases like cancer, heart disease and type 2 diabetes are multifactorial: risk for these diseases depends on multiple genetic and environmental factors. To date, however, epidemiological studies searching for genetic markers associated with disease risk have considered the effect of a single genetic factor, averaged over all other factors. If the effect of a genetic variant differs across strata defined by environmental exposures, then it is possible that the marginal approach will fail to detect the variant. In some situations, considering possible genetic effect modification by measured exposures can increase researchers'ability to detect genetic markers of disease. Most of the proposed methods for improving power to detect causal loci by considering gene-environment interaction focus on a single locus and a single environmental exposure. When more than one exposure might modify with a genetic effect, these methods force investigators either to guess a priori which exposure is the most likely modifier or to test individual exposures in series, leading to an increase in multiple testing penalty and a loss of power. We propose two analytic frameworks that flexibly model the interactions between a genetic marker and multiple measured exposures. We hypothesize that these approaches will be more powerful than tests that focus on a single exposure, or consider multiple exposures individually, in series. Successful completion of our aims will provide researchers with tools to improve their ability to identify genetic variants associated with complex human traits, which will in turn lead to a better understanding of the multifactorial mechanisms underlying human disease and potential improvements in risk prediction and prevention programs.

Public Health Relevance

Common, complex diseases like cancer, heart disease and type 2 diabetes are multifactorial: risk for these diseases depends on multiple genetic and environmental factors. We propose to develop new statistical methods to improve researchers'ability to identify genetic risk loci whose effect may be masked or amplified in particular environments. Our methods can be used to deepen understanding of the multifactorial mechanisms underlying human disease and improve in risk prediction and prevention programs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21CA165920-02
Application #
8431358
Study Section
Biomedical Computing and Health Informatics Study Section (BCHI)
Program Officer
Mechanic, Leah E
Project Start
2012-02-17
Project End
2014-01-31
Budget Start
2013-02-01
Budget End
2014-01-31
Support Year
2
Fiscal Year
2013
Total Cost
$151,810
Indirect Cost
$57,810
Name
Harvard University
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Slade, Emily; Kraft, Peter (2016) Leveraging Methylome-Environment Interaction to Detect Genetic Determinants of Disease. Hum Hered 81:26-34
Aschard, Hugues; Vilhjálmsson, Bjarni J; Greliche, Nicolas et al. (2014) Maximizing the power of principal-component analysis of correlated phenotypes in genome-wide association studies. Am J Hum Genet 94:662-76
Wu, Chen; Chang, Jiang; Ma, Baoshan et al. (2013) The case-only test for gene-environment interaction is not uniformly powerful: an empirical example. Genet Epidemiol 37:402-7
Hiraki, Linda T; Major, Jacqueline M; Chen, Constance et al. (2013) Exploring the genetic architecture of circulating 25-hydroxyvitamin D. Genet Epidemiol 37:92-8
Aschard, Hugues; Zaitlen, Noah; Tamimi, Rulla M et al. (2013) A nonparametric test to detect quantitative trait loci where the phenotypic distribution differs by genotypes. Genet Epidemiol 37:323-33
Aschard, Hugues; Lutz, Sharon; Maus, Bärbel et al. (2012) Challenges and opportunities in genome-wide environmental interaction (GWEI) studies. Hum Genet 131:1591-613
Azzato, Elizabeth M; Pharoah, Paul D P; Harrington, Patricia et al. (2010) A genome-wide association study of prognosis in breast cancer. Cancer Epidemiol Biomarkers Prev 19:1140-3